Skip to main content
Regulatory Affairs NewsletterRegulatory Affairs Newsletter ArchiveUK Government Updates Regulatory Affairs NewsletterUK Government Updates Regulatory Affairs Newsletter Archive

MHRA Update (WC 30 Sept)

Clinical investigations guidance Page summary: Information on how to notify the MHRA of your intention to carry out a clinical investigation for medical devices. Change made: Updated section on ‘Amendments’ to reflect changes to the process. Time updated: 9:34am, 26 September 2024 Access Consortium: joint pipeline meetings Page summary: The Access Consortium is offering joint pipeline meetings to pharmaceutical and…
Ben Kemp
October 2, 2024
Regulatory Affairs NewsletterRegulatory Affairs Newsletter ArchiveUK Government Updates Regulatory Affairs NewsletterUK Government Updates Regulatory Affairs Newsletter Archive

MHRA Update (WC 16 Sept)

MHRA consultation on statutory fees – proposals on ongoing cost recovery Page summary: Consultation on proposals to update the MHRA’s statutory fees to ensure they continue to recover their costs. Change made: Following early feedback from customers and stakeholders, we have clarified some terms in the consultation document relating to Priority 2: The MHRA proposes to amend its existing Medical…
Ben Kemp
September 18, 2024